Capstone Investment Advisors
NUVB icon

Capstone Investment Advisors’s Nuvation Bio NUVB Stock Holding History

Capstone Investment Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$481K Buy
112,170
+98,018
+693% +$546K ﹤0.01% 1151
2025
Q4 		$127K Buy
+14,152
New +$87.7K ﹤0.01% 1522
2021
Q2 		– Sell
-28,338
Closed -$296K – 1822
2021
Q1 		$296K Buy
+28,338
New +$317K ﹤0.01% 1364

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors's NUVB Position: Q1 2026 in Review

Capstone Investment Advisors increased its Nuvation Bio (NUVB) stake by 693% in Q1 2026, buying an estimated $546K and bringing the position to 112,170 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Capstone Investment Advisors first reported a position in NUVB in Q1 2021 and has held it in 3 quarters since. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Capstone Investment Advisors held 112,170 shares of Nuvation Bio worth $481K as of Q1 2026.
  • Capstone Investment Advisors bought 98,018 Nuvation Bio shares in Q1 2026, an estimated $546K.
  • Nuvation Bio made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1151 holding.
  • Capstone Investment Advisors first reported a position in Nuvation Bio in Q1 2021 and has held it in 3 quarters since.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.